Catalyst Wire Dossier Catalyst Wire Dossier

OPZELURA (Ruxolitinib) Cream

ruxolitinib
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OPZELURA (Ruxolitinib) Cream, covering 2024-11-05 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo [Phase 2]

See pricing